V02.09.[ADDRESS_494289] of Rivaroxaban or Api[INVESTIGATOR_393939] (RAMBLE ) 
 
[STUDY_ID_REMOVED]  
 
The primary comparison is the frequency of study -defined abnormal uterine bleeding between women 
treated with api[INVESTIGATOR_3822], versus women treated with rivaroxaban. The plan was to compare these 
frequencies using 95% confidence intervals for the difference in proportions.  
 